Development · 27 Oct 2026
DRREDDY, full dossier4 publishers have reported this development. Each act of reporting is below, cited.
Dr Reddy's Laboratories reported a consolidated net profit of Rs 913.4 crore for the September quarter, down from Rs 1,426.8 crore in the corresponding quarter last year.
Dr Reddy's Labs reported a 36 per cent YoY fall in net profit to Rs 913 crore, while revenue declined nearly 2 per cent on a yearly basis to Rs 8,670.8 crore for the quarter ended September 30, 2026.
Dr Reddy's Laboratories reported a 36 per cent year-on-year decline in Q2 net profit.
Dr Reddy's Laboratories reported a 31.3% year-on-year decline in consolidated net profit for the September quarter, with net profit falling to Rs 925 crore from Rs 1,347 crore a year earlier.
16 Nov 2026 · 1 publisher
14 Nov 2026 · 1 publisher
13 Nov 2026 · 1 publisher
12 Nov 2026 · 1 publisher
This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.